Clinical Trials Browser

OTHER × Hodgkin Disease × temsirolimus × Clear all

NCT00838955 2024-07-10

Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma

Phase 2 Terminated

Hodgkin Disease